DOI:
10.1055/s-00042229
Geriatrie up2date
LinksClose Window
References
Gerstein HC, Colhoun HM, Dagenais GR. et al.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet 2019;
394: 121-130
DOI: 10.1016/S0140-6736(19)31149-3. (PMID: 31189511)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.